Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
See Latest ArticlesImmunomodulation of Multiple Myeloma Bone Disease
Clinical Reviews in Bone and Mineral Metabolism , 09/25/09
Grano M et al. – Multiple myeloma (MM) is a clonal malignancy of terminally differentiated plasma cells. Myeloma patients often have extensive skeletal complications, including bone pain, osteolytic lesions and pathological fractures, which represent the major cause of morbidity and possible mortality. This review focuses on molecules produced by cells of immune system able to induce bone destruction in MM bone disease.
Today in Myeloproliferative Dz...keeping you current
Receive free subspecialty "5-minute updates" via email
Retrospective comparison of mobilization methods for autologous stem cell transplantation in multiple myeloma
American Journal of Hematology, 11/10/09
Serum albumin level is a significant prognostic factor reflecting disease severity in symptomatic multiple myeloma
Annals of Hematology, 10/27/09
Prognostic molecular markers in myelodysplastic syndromes
Expert Review of Hematology, 10/22/09
Sponsor
Article Search
Sponsor
Sponsor